Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 9.93%8.35M | -1.58%7.74M | -17.34%7.35M | -18.34%31.56M | -34.10%7.47M | -24.47%7.59M | -11.23%7.86M | 5.75%8.9M | 33.81%38.65M | 53.99%11.33M |
| Cost of revenue | 6.46%34.38M | 230.06%1.75M | 42.65%32.3M | |||||||
| Gross profit | -144.47%-2.82M | -26.56%6.12M | 1.76%6.35M | |||||||
| Operating expense | 22.33%12.19M | 71.41%9.97M | ||||||||
| Staff costs | ---- | ---- | ---- | 139.23%2.53M | ---- | ---- | ---- | ---- | 35.30%1.06M | ---- |
| Other operating expenses | ---- | ---- | ---- | 8.45%9.66M | ---- | ---- | ---- | ---- | 77.01%8.91M | ---- |
| Operating profit | 82.40%-931K | 48.17%-1.57M | -203.33%-2.92M | -315.29%-15.02M | -132.52%-5.69M | -935.03%-5.29M | -136.43%-3.03M | -1,217.81%-962K | -948.48%-3.62M | -265.46%-2.45M |
| Net non-operating interest income (expenses) | -280.64%-1.58M | -1,141.67%-447K | -121.36%-415.59K | |||||||
| Non-operating interest income | ---- | ---- | ---- | --103.69K | ---- | ---- | ---- | ---- | --0 | ---- |
| Non-operating interest expense | -40.36%235K | -38.26%276K | -31.83%317K | 305.59%1.69M | 30.14%367K | 1,690.91%394K | 1,141.67%447K | 511.84%465K | 113.20%415.59K | 404.26%282K |
| Net investment income | 166.38K | |||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 184.28%7.23M | 902.11%1.42M | 82.76%2.54M | |||||||
| Special income (charges) | 146.31%152.65K | -883.58%-329.63K | ||||||||
| Less:Impairment of capital assets | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --391.07K | ---- |
| Less:Other special charges | ---- | ---- | ---- | ---150K | ---- | ---- | ---- | ---- | ---- | ---- |
| Less:Write off | ---- | ---- | ---- | 95.69%-2.65K | ---- | ---- | ---- | ---- | -34.15%-61.44K | ---- |
| Other non-operating income (expenses) | -29.36%309.02K | 90.31%437.48K | ||||||||
| Income before tax | 146.26%1.06M | 128.49%586K | -134.29%-2.28M | -533.02%-8.74M | -197.88%-4.07M | -3,673.44%-2.29M | -457.45%-2.06M | -435.99%-971K | -175.62%-1.38M | -405.33%-1.37M |
| Income tax | 735.71%1.17M | 0 | 0 | -301.43%-473.62K | -560.43%-1.08M | 140K | 0 | 0 | 249.39%235.13K | 249.20%235K |
| Net income | 95.39%-112K | 128.49%586K | -134.29%-2.28M | -411.62%-8.27M | -86.50%-2.98M | -3,892.19%-2.43M | -457.45%-2.06M | -435.99%-971K | -191.89%-1.62M | -521.32%-1.6M |
| Net income continuous operations | 95.39%-112K | 128.49%586K | -134.29%-2.28M | -411.62%-8.27M | -86.50%-2.98M | -3,892.19%-2.43M | -457.45%-2.06M | -435.99%-971K | -191.89%-1.62M | -521.32%-1.6M |
| Noncontrolling interests | 43.66%-191K | 5.18%-293K | -19.86%-332K | -171.18%-1.26M | 7.54%-331K | -260.64%-339K | -2,709.09%-309K | -277K | -462.89K | -358K |
| Net income attributable to the company | 103.78%79K | 150.29%879K | -179.97%-1.94M | -508.13%-7.01M | -113.61%-2.65M | -1,421.52%-2.09M | -388.27%-1.75M | -340.14%-694K | -165.57%-1.15M | -427.05%-1.24M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 103.78%79K | 150.29%879K | -179.97%-1.94M | -508.13%-7.01M | -113.61%-2.65M | -1,421.52%-2.09M | -388.27%-1.75M | -340.14%-694K | -165.57%-1.15M | -427.05%-1.24M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 103.75%0.0012 | 149.81%0.0134 | -177.57%-0.0297 | -507.34%-0.1075 | -112.04%-0.0405 | -1,433.33%-0.032 | -389.09%-0.0269 | -343.18%-0.0107 | -165.56%-0.0177 | -429.31%-0.0191 |
| Diluted earnings per share | 103.75%0.0012 | 149.81%0.0134 | -177.57%-0.0297 | -507.34%-0.1075 | -112.04%-0.0405 | -1,433.33%-0.032 | -389.09%-0.0269 | -343.18%-0.0107 | -165.56%-0.0177 | -429.31%-0.0191 |
| Dividend per share | ||||||||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.